First Eagle Investment Management’s AngioDynamics ANGO Stock Holding History

First Eagle Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.6M	Buy	276,435 +700	+0.3%	+$7.97K	0.01%	314
2026 Q1	$3.14M	Buy	275,735 +8,000	+3%	+$86.7K	0.01%	301
2025 Q4	$3.44M	Sell	267,735 -9,600	-3%	-$119K	0.01%	287
2025 Q3	$3.1M	Sell	277,335 -28,000	-9%	-$270K	0.01%	299
2025 Q2	$3.03M	Sell	305,335 -72,500	-19%	-$710K	0.01%	300
2025 Q1	$3.55M	Sell	377,835 -32,500	-8%	-$342K	0.01%	290
2024 Q4	$3.76M	Buy	410,335 +16,221	+4%	+$119K	0.01%	288
2024 Q3	$3.07M	Buy	394,114 +175,745	+80%	+$1.27M	0.01%	294
2024 Q2	$1.32M	Buy	+218,369	New	+$1.35M	﹤0.01%	337

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management's ANGO Position: Q2 2026 in Review

First Eagle Investment Management increased its AngioDynamics (ANGO) stake by 0.25% in Q2 2026, buying an estimated $7.97K and bringing the position to 276,435 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #314.

First Eagle Investment Management first reported a position in ANGO in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.76M in Q4 2024. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

First Eagle Investment Management held 276,435 shares of AngioDynamics worth $3.6M as of Q2 2026.
First Eagle Investment Management bought 700 AngioDynamics shares in Q2 2026, an estimated $7.97K.
AngioDynamics made up 0.01% of First Eagle Investment Management's portfolio in Q2 2026, its #314 holding.
First Eagle Investment Management first reported a position in AngioDynamics in Q2 2024 and has held it in 9 quarters since.
First Eagle Investment Management's AngioDynamics position peaked at $3.76M in Q4 2024.
162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on First Eagle Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.